Keyphrases
Pediatric Oncology
100%
Group Program
12%
Relapsed ALL
12%
Group Studies
12%
Relapsed AML
12%
Georgia
12%
Allogeneic Bone Marrow Transplantation
12%
Infant Leukemia
8%
Single Institution
6%
Laboratory Research
6%
P53 Tumor Suppressor Gene
6%
Arkansas
6%
Gene Pathway
6%
Molecular Biology
6%
Dose Escalation
6%
Specific Intent
6%
Florida
6%
Solid Tumors
6%
Metabolism
6%
Antineoplastic Agents
6%
Resistance Mechanisms
6%
Alkylating Agents
6%
Translational Research Programs
6%
High Dose
6%
Aberrations
6%
Children with Cancer
6%
Cancer Center
6%
Atlanta
6%
Clinical Trials
6%
Transplantation
6%
Haploidentical
6%
Neoplastic Disease
6%
Salvage Chemotherapy
6%
Leukemia Cells
6%
Refractory Solid Tumors
6%
In Vitro Sensitivity
6%
Idarubicin
6%
CD34+ Cells
6%
Refractory Neuroblastoma
6%
Emory University
6%
Molecular Neuro-oncology
6%
Intergroup Study
6%
Human Hematopoiesis
6%
Mississippi
6%
Group Investigation
6%
Chemotherapy
6%
Group Members
6%
AML Cells
6%
Committee Member
6%
Protocol Development
6%
Melphalan
6%
Standard Risk
6%
Biological Response Modifiers
6%
Busulfan
6%
Interleukin-6
6%
Methotrexate
6%
Diverse Populations
6%
High Risk
6%
Progenitor Cells
6%
Tumor Suppressor Gene
6%
Peripheral Blood
6%
Xenogeneic
6%
Cyclophosphamide
6%
Medicine and Dentistry
Childhood Cancer
100%
Acute Myelogenous Leukemia
25%
Solid Malignant Neoplasm
12%
Tumor Suppressor Gene
12%
Autologous Bone Marrow Transplantation
12%
Clinical Trial
6%
Protein P53
6%
Ganglioneuroblastoma
6%
Vincristine
6%
Malignant Neoplasm
6%
Anticarcinogen
6%
Base
6%
Neoplasm
6%
Leukemia Cell
6%
Group Trial
6%
Chemotherapeutic Agent
6%
Interleukin-6
6%
Infusion
6%
Biological Response Modifier
6%
Progenitor Cell
6%
Translational Research
6%
Melphalan
6%
Cyclophosphamide
6%
Hematopoiesis
6%
In Vitro
6%
Methotrexate
6%
Neuro-Oncology
6%
Alkylating Antineoplastic Agent
6%
Drug Megadose
6%
Infancy
6%
Busulfan
6%
Idarubicin
6%